While calcium entry blockers have a beneficial influence on the postischemic recovery of the nonhypertrophied heart, their influence on the hypertrophied heart has not been determined. The aim of this study was to assess postischemic recovery of myocardial performance and energy metabolites in rat hearts with left ventricular hypertrophy pretreated either chronically or acutely with verapamil. Left ventricular hypertrophy was induced by suprarenal constriction of the abdominal aorta. Hemodynamics and phosphorus 31 magnetic resonance spectra were monitored simultaneously in the isolated hearts during control perfusion, after 30 minutes of global ischemia, and after 30 minutes of reperfusion. All hypertrophied hearts had significantly higher rate-pressure products than normal hearts. Compared with normal hearts, oxygen consumption was significantly lower in all hypertrophied hearts, especially untreated hypertrophied hearts. Also, before ischemia all normal or hypertrophied hearts (treated or untreated) began with comparable phosphorylation potentials (i.e., the supply of energy was not significantly different). Postischemic recovery was not related to energy supply-oxygen demand before onset of ischemia. Furthermore, it was not related to energy levels or intracellular pH during ischemia. For postischemic recovery, the rate-pressure product was 40±t5% in the hypertrophied heart, 83+±5% in the normal, 100±t3% in the hypertrophied heart chronically treated with verapamil, and 82 ±5% in the hypertrophied heart acutely treated with verapamil. The degree of recovery was related to coronary flow both before and after ischemia. The latter is important for flushing deleterious metabolites and ions from the interstitial space as well as for delivery of oxygen and substrate to the myocardium. (Circulation 1989;80:1837-1845 L eft ventricular hypertrophy caused by systemic hypertension in association with coronary ischemic heart disease has been recognized as a major risk factor for sudden death, postinfarction heart failure, and cardiac rupture. 
While calcium entry blockers have a beneficial influence on the postischemic recovery of the nonhypertrophied heart, their influence on the hypertrophied heart has not been determined. The aim of this study was to assess postischemic recovery of myocardial performance and energy metabolites in rat hearts with left ventricular hypertrophy pretreated either chronically or acutely with verapamil. Left ventricular hypertrophy was induced by suprarenal constriction of the abdominal aorta. Hemodynamics and phosphorus 31 magnetic resonance spectra were monitored simultaneously in the isolated hearts during control perfusion, after 30 minutes of global ischemia, and after 30 minutes of reperfusion. All hypertrophied hearts had significantly higher rate-pressure products than normal hearts. Compared with normal hearts, oxygen consumption was significantly lower in all hypertrophied hearts, especially untreated hypertrophied hearts. Also, before ischemia all normal or hypertrophied hearts (treated or untreated) began with comparable phosphorylation potentials (i.e., the supply of energy was not significantly different). Postischemic recovery was not related to energy supply-oxygen demand before onset of ischemia. Furthermore, it was not related to energy levels or intracellular pH during ischemia. For postischemic recovery, the rate-pressure product was 40±t5% in the hypertrophied heart, 83+±5% in the normal, 100±t3% in the hypertrophied heart chronically treated with verapamil, and 82 ±5% in the hypertrophied heart acutely treated with verapamil. The degree of recovery was related to coronary flow both before and after ischemia. The latter is important for flushing deleterious metabolites and ions from the interstitial space as well as for delivery of oxygen and substrate to the myocardium. (Circulation 1989; 80:1837 -1845 L eft ventricular hypertrophy caused by systemic hypertension in association with coronary ischemic heart disease has been recognized as a major risk factor for sudden death, postinfarction heart failure, and cardiac rupture. [1] [2] [3] [4] Myocardial infarct size in a certain area at risk is larger in hypertensive dogs with left ventricular hypertrophy compared with control dogs,5'6 and the Supported by the George D. Smith Foundation and NIH grant AA-07413-01. P.T.B. is supported by the Swiss Science Foundation. myocardium16 in normal dog hearts. Preservation of high-energy phosphate stores17-21 and sarcolemmal enzymatic activity22 by verapamil during ischemia has been documented. Deleterious disturbances of transmembranous electrolyte exchange and intracellular depletion of adenosine triphosphate (ATP) caused by ischemic cell damage and reperfusion might be prevented. Because many infarcts are now being reperfused by thrombolytic and other interventions, it is important to determine whether verapamil protects the hypertrophied myocardium during an episode of ischemia and subsequent reperfusion.
Therefore, the aims of the current study were 1) to compare the postischemic recovery of mechanical performance and high energy phosphate stores in chronic pressure overload left ventricular hypertrophy with normal hearts and 2) to determine whether verapamil, administered either acutely or chronically, provides protection of the hypertrophied myocardium during ischemia and reperfusion.
Methods

Animals
Sprague-Dawley rats, weighing 300-350 g, were used. Normal healthy rats served as controls (n = 12). Left ventricular hypertrophy was caused by constriction of the suprarenal abdominal aorta.23 During pentobarbital anesthesia, the suprarenal abdominal aorta was banded, resulting in a lumen constriction of approximately 50%, which caused chronic pressure overload of the left ventricle. Animals were randomly assigned to three groups. One group of the aortic-constricted rats received no verapamil treatment (n=18); a second group received 1.2 g/l verapamil in drinking water (n = 12) starting after surgery until day killed; and a third group received 1.2 g/l verapamil in drinking water for 3 days before being killed (n = 11). Not all experiments were carried out on the total numbers because of technical problems with magnetic resonance spectroscopic (MRS) signal acquisition. Four rats from each group were used for freeze-clamping to determine ATP and creatinine (Cr) concentrations. All rats were kept in the same room and given food and water ad libitum. The rats were killed 3 weeks after aortic banding. After successful surgery resulting in uniform left ventricular hypertrophy (35-45% increase in dry heart wt/body wt), no animals were rejected from the study. All work was done in accordance with guidelines from the animal research committee of the University of California San Francisco.
Perfused Heart Model
The rats were anesthetized with ether, and the hearts were excised rapidly through a midline sternotomy and perfused within 30- obtained at a 15-second recycle time, and correction factors for phosphocreatine (PCr) and inorganic phosphate (Pi) were determined (3% and 5%, respectively). Chemical shifts were referred to the resonance position of PCr. The peaks characteristic of Pi, PCr, and phosphate groups of ATP were identified. Each spectrum and the corresponding areas were numerically integrated after defining the baseline. Phosphate peaks were quantitated using manual electronic planimetry27-29 and estimated for whole heart detection by comparison to a capillary tube of standard methylene diphosphonic acid fixed inside the nuclear magnetic resonance The total loss of purine nucleosides in the coronary effluent for 5 minutes of reperfusion was significantly less in hypertrophy plus chronic verapamil compared with hypertrophy with no treatment Values given are the total content as measured in the total coronary effluent and normalized for heart weight. Nucleosides accumulated in the interstitial space during ischemia and were released in the first 5 minutes of reperfusion. Verapamil helped prevent the release of nucleotide breakdown. Representative 31P-MRS spectra of each group during control perfusion, at 30 minutes of ischemia, and at 30 minutes of reperfusion are shown in Figure 2 . The time course of changes in Pi, PCr, ,3-ATP, and pH during ischemia and reperfusion are shown in Table 2 Table 2 ). Phosphocreatine recovered in all except the untreated hypertrophy hearts ( Figure 3 , Table 2 ). Because of the loss of the nucleotide pool during ischemia, 8 -ATP recovered poorly in all groups but the least in the untreated hypertrophy group (Figure 3 , Table 2 ).
The intracellular pH fell severely in all groups but most severely in the hypertrophy group treated chronically with verapamil ( Figure 3 , Table 2 ).
Coronary Flow
As shown in Figure 4 and 
Oxygen Consumption
As shown in Figure 5 and Table 1 Before ischemia, the phosphorylation potential was not significantly different among the four groups ( Figure 6 , Table 2 ). The phosphorylation potential remained significantly depressed postischemia in the untreated hypertrophy group (p<0.05), but returned to values not significantly different from control in all other groups ( Figure 6 , Table 2 ).
Discussion
The aim of the present study was to assess the effects of verapamil treatment on postischemic recovery relative to myocardial mechanics and energetics of rats with left ventricular hypertrophy induced by chronic pressure overload. We compared 1) untreated rats with hypertrophied hearts, 2) hypertrophied hearts from rats treated acutely with verapamil, 3) hypertrophied hearts from rats treated chronically with verapamil, and 4) normal hearts. All hypertrophied hearts, untreated or treated acutely or chronically with verapamil, had significantly higher dry heart weight-to-body weight ratios compared with controls and were not significantly different in dry heart weight-to-body weight ratios among themselves. After 30 minutes of ischemia and reperfusion, hypertrophied rat hearts treated chronically with verapamil-recovered ratepressure product completely (100+3% of the baseline value). Rate-pressure product recovered 82 ±5% in hypertrophied hearts treated acutely with verap- Coronary blood flow and oxygen consumption for untreated hypertrophied hearts was significantly lower than that for normal hearts (Table 1 ). This observation was true when coronary flow was not corrected for heart weight ( Table 1) or calculated as a factor of heart weight (wet) (Figure 4 ). The diminished coronary flow correlated with the depressed oxygen consumption in the untreated hypertrophied hearts whether oxygen consumption was corrected for dry heart weight ( Table 1 and Figure 5 ) or expressed as a factor of wet heart weight as described in the "Results." Similar findings were obtained for the spontaneously hypertensive rat, another form of hypertension. 35 The shift toward isomyosin V3 may be assuaged by calcium entry blockers.34 Coronary flow was not significantly different between normal and hypertrophied hearts treated chronically with verapamil. Coronary flow from both was significantly higher than from hypertrophied hearts treated acutely with verapamil or not treated at all, although hypertrophied hearts treated acutely with verapamil had a significantly higher coronary flow compared with untreated hypertrophied hearts. Postischemic recovery of hypertrophied hearts was directly related to coronary flow before ischemia. Verapamil helped improve coronary flow by improving the calcium homeostasis of the vasculature. Similar findings were also obtained with the working heart model and the spontaneously hypertensive rat. 26, 34 The lower coronary flow with hypertension may be due to an imbalance in the calcium homeostasis of the heart36 leading to structural and functional abnormalities of the coronary vessels.8-10 A shift in isomyosins and a resultant reduction in oxygen requirements may then occur in rodents to compensate for the depressed coronary flow.
for sudden death in patients with coronary artery disease associated with left ventricular hypertrophy is increased fivefold compared with the general population.3,4 In the presence of increased heart size and arterial pressure, heart failure and cardiac rupture after infarction are more frequent.2 In dogs with left ventricular hypertrophy and systemic hypertension, coronary occlusion is associated with a threefold increase in sudden death, a substantial increase in infarct size,5,6 and a greater susceptibility for serious arrhythmias7 than in animals with normal cardiac mass. Thus, the course after a coronary ischemic event tends to be more severe in the presence of left ventricular hypertrophy. In the studies described here, hearts from rats subjected to aortic stenosis but not treated with verapamil recovered poorly after 30 minutes of global ischemia compared with normal hearts or hypertrophied hearts treated acutely or chronically with verapamil.
In untreated left ventricular hypertrophy, minimal coronary resistance was increased compared with normal hearts. Functional9"10 and anatomic12,20 alterations of the coronary vasculature in chronic pressure-overload hypertrophy are well known. In spontaneously hypertensive rats treated with a slow channel calcium entry blocker, both hypertension and left ventricular hypertrophy were still present, but myocardial capillary density was comparable to that of normal Wistar-Kyoto rats.37 Because verapamil exerts a coronary vasodilator effect, thereby increasing coronary blood flow, it may also induce proliferation of myocardial capillaries.38 In this study, minimal coronary resistance in verapamil-treated hypertrophied hearts was diminished compared with untreated hypertrophied hearts. Alterations of the coronary circulation in untreated pressure-overload left ventricular hypertrophy may partially account for the impaired postischemic recovery, causing a delayed supply of nutrients and oxygen and a retarded removal of noxious metabolites during reperfusion. Verapamil treatment may minimize these deleterious changes of the coronary vasculature and, additionally, may protect functional integrity of mitochondrial and cell membranes during ischemia. However, the sensitive protective effect conferred by acute as well as chronic verapamil administration indicates that other mechanisms must also be operative.
Verapamil has been shown to exert a protective effect on the normal myocardium during ischemia13-21 and acidosis. Inducing global ischemia stops the supply of nutrients and oxygen to the heart as well as the removal of deleterious products within seconds in all heart preparations. The rapid increase in inorganic phosphate, the reduction in muscle stretch after the fall of perfusion pressure, and a decrease of the action potential duration may account for the decline of left ventricular developed pressure to zero within the first few minutes of ischemia. [41] [42] [43] The ATP breakdown was attenuated in verapamiltreated hypertrophied hearts, resulting in a significantly higher ATP level at 30 minutes of ischemia compared with untreated hypertrophied and normal hearts. This protective effect of verapamil on ATP stores has been described previously in normal hearts18,'9'2' and might be caused by a reduced ATP use due to lower intracellular calcium levels.18,21 During reperfusion, fewer membrane-diffusible nudleosides were washed out, which may reflect quantitatively diminished accumulation of these nucleosides during ischemia.1 ,21 Although pH was lowest at 30 minutes of ischemia in the chronic verapamiltreated group, this group, nevertheless, showed the best postischemic recovery. Furthermore, even though Pi was highest in the two verapamil-treated groups at 30 minutes of ischemia, these two groups, again, showed the best postischemic recovery.
It might be presumed that normal hearts pretreated with verapamil might show an even better recovery during reperfusion. Normal animals pretreated with verapamil were not investigated in the current study because the salutary influence of verapamil on the normal heart during ischemia has already been established.13-22 A previous study18 has shown a salutary effect of verapamil on highenergy phosphate compounds of the reperfused ischemic myocardium of normal rats.
In summary, the criteria for postischemic recovery were retention of rate-pressure product and the phosphorylation potential. Postischemic recovery of the hypertrophied heart was directly related to coronary flow before inducing ischemia. Acute or chronic verapamil treatment of the hypertrophied heart may improve postischemic recovery by its improvement of coronary flow. The results obtained here by inducing hypertrophy with aortic stenosis, thereby causing hypertension, may not be common to all types of hypertrophy. Furthermore, the isolated perfused heart is a hyperperfused system.43 The isolated heart, as described here, has excessive coronary flow and oxygen delivery43 so that the results obtained in this study may not occur in situ.
